Back to Trades
Total Value
$300.0K
Net $300.0K bought
Filing Date
Jul 24, 2026
2 transactions
Purchases
$300.0K
2 transactions
Trade Summary
On Jul 14, 2026 through Jul 20, 2026, Choo Chee Kong, Director, 10% Owner, purchased $300.0K of CytoMed Therapeutics Ltd (GDTC) across 2 transactions. The filing covers ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED and reflects net buying of $300.0K. Reported prices ranged from $1.50. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- CytoMed Therapeutics Ltd
- Ticker Symbol
- GDTC
- CIK
- 0001873093
Insider Information
- Name
- Choo Chee Kong
- Role
- Director, 10% Owner
Filing Details
- Filing Date
- Jul 24, 2026
- Transaction Date
- Jul 14, 2026
- Accession Number
- 0001493152-26-034654
- Form Type
- 4
- Net Trading Amount
- $300.0K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 14, 2026 | ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED | 100,000 | $1.50 | Purchase | $150.0K |
| Jul 20, 2026 | ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED | 100,000 | $1.50 | Purchase | $150.0K |
Want live alerts when Choo Chee Kong trades again?
Download Insider Trades to track GDTC, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)This Form 4/A amends the Form 4 originally filed on July 24, 2026 solely to correct the acquisition/disposition indicator in Column 4 of Table I from "D" to "A". No other changes have been made.